author-photo

Francesca Bonifazi

University of Bologna

224

Papers

4716

Citations

Citation Trend

Filter By

Papers (156) Sort By

Journal Conference Others

Incidence, risk factors and complications of ocular graft-versus-host disease following hematopoietic stem cell transplantation: Incidence, risk factors and complications of ocular GVHD.

2021 American Journal of Ophthalmology
Show All
- Source
- Cite
- Save
Citations (2)
Ruxolitinib Vs Best Available Therapy in Patients With Steroid-Refractory/Dependent Chronic GRAFT-VS-HOST Disease (CGVHD): Subgroup Analyses of Overall Response Rate in The Phase 3 Reach3 Trial

2021
Show All
- Source
- Cite
- Save
Citations (1)
Decades of Progress in Allogeneic Stem Cell Transplantation for Multiple Myeloma

2021
Show All
- Source
- Cite
- Save
Citations (0)
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome.

2021 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Long-term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high-risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party-EBMT.

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
Availability of HLA-allele-matched unrelated donors and registry size: Estimation from haplotype frequency in the Italian population

2021 Human Immunology
Show All
- Source
- Cite
- Save
Citations (0)
FDG-PET IMAGING AND RADIOMICS IN RESPONSE ASSESSMENT OF LYMPHOMA PATIENTS UNDERGOING CAR T-CELL THERAPY

2021 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients.

2021 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (1)